Login to Your Account

Osiris Snags $225M Contract from DoD for Radiation Therapy

By Donna Young

Monday, January 7, 2008
Osiris Therapeutics Inc. won a contract potentially worth $224.7 million from the Department of Defense (DoD) to develop its mesenchymal stem cell therapy Prochymal to treat gastrointestinal injuries resulting from radiation exposure. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription